Differential expression of CD146 in tissues and endothelial cells derived from infantile haemangioma and normal human skin

Journal of Pathology

Volumn 201, Issue 2, 2003, Pages 296-302

  Li, Qing ^a   Yu, Ying ^b   Bischoff, Joyce ^b   Mulliken, John B ^b   Olsen, Bjorn R ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Benign tumour; CD146; Endothelial cells; Haemangioma; Pericyte like cells

Indexed keywords

ANTIGEN; BIOLOGICAL MARKER; CD146 ANTIGEN; CELL ADHESION MOLECULE; LYMPHOCYTE ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; CANCER STAGING; CAUCASIAN; CELL CULTURE; CELL ISOLATION; CHILD CARE; CONTROLLED STUDY; ENDOTHELIUM CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFANT; PERICYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SKIN HEMANGIOMA; TUMOR GROWTH; TUMOR REGRESSION; VASCULAR ENDOTHELIUM;

ANTIGENS, CD; ANTIGENS, CD146; ANTIGENS, CD31; BIOLOGICAL MARKERS; ENDOTHELIUM, VASCULAR; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GLUCOSE TRANSPORTER TYPE 1; HEMANGIOMA; HUMANS; MEMBRANE GLYCOPROTEINS; MONOSACCHARIDE TRANSPORT PROTEINS; NEURAL CELL ADHESION MOLECULES; PERICYTES; SKIN NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0141961138     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1443     Document Type: Article

References (23)

1. Lehmann JM, Riethmuller G, Johnson JP. MUC18, a marker of tumor progression in human melanoma, shows sequence similarity to the neural cell adhesion molecules of the immunoglobulin superfamily. Proc Natl Acad Sci U S A 1989; 86: 9891-9895.
2. Sers C, Kirsch K, Rothbacher U, Riethmuller G, Johnson JP. Genomic organization of the melanoma-associated glycoprotein MUC18: implications for the evolution of the immunoglobulin domains. Proc Natl Acad Sci U S A 1993; 90: 8514-8518.
3. Sers C, Riethmuller G, Johnson JP. MUC18, a melanoma-progression associated molecule, and its potential role in tumor vascularization and hematogenous spread. Cancer Res 1994; 54: 5689-5694.
4. Shih IM, Kurman RJ. Expression of melanoma cell adhesion molecule in intermediate trophoblast. Lab Invest 1996; 75: 377-388.
5. Shih IM. The role of CD146 (Mel-CAM) in biology and pathology. J Pathol 1999; 189: 4-11.
6. Bardin N, Anfosso F, Masse JM, et al. Identification of CD146 as a component of the endothelial junction involved in the control of cell-cell cohesion. Blood 2001; 98: 3677-3684.
7. Schlagbauer-Wadl H, Jansen B, Muller M, et al. Influence of MUC18/MCAM/CD146 expression on human melanoma growth and metastasis in SCID mice. Int J Cancer 1999; 81: 951-955.
8. Xie S, Luca M, Huang S, et al. Expression of MCAM/MUC18 by human melanoma cells leads to increased tumor growth and metastasis. Cancer Res 1997; 57: 2295-2303.
9. Shih LM, Hsu MY, Palazzo JP, Herlyn M. The cell-cell adhesion receptor Mel-CAM acts as a tumor suppressor in breast carcinoma. Am J Pathol 1997; 151: 745-751.
10. Kraling BM, Bischoff J. A simplified method for growth of human microvascular endothelial cells results in decreased senescence and continued responsiveness to cytokines and growth factors. In Vitro Cell Dev Biol Anim 1998; 34: 308-315.
11. North PE, Waner M, Mizeracki A, et al. A unique microvascular phenotype shared by juvenile hemangiomas and human placenta. Arch Dermatol 2001; 137: 559-570.
12. North PE, Waner M, Mizeracki A, Mihm MC Jr. GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol 2000; 31: 11-22.
13. Johnson JP, Lehmann JM, Stade BG, Rothbacher U, Sers C, Riethmuller G. Functional aspects of three molecules associated with metastasis development in human malignant melanoma. Invasion Metastasis 1989; 9: 338-350.
14. Johnson JP. Identification of molecules associated with the development of metastasis in human malignant melanoma. Invasion Metastasis 1994; 14: 123-130.
15. Shih IM, Elder DE, Speicher D, Johnson JP, Herlyn M. Isolation and functional characterization of the A32 melanoma-associated antigen. Cancer Res 1994; 54: 2514-2520.
16. Bardin N, Frances V, Lesaule G, Horschowski N, George F, Sampol J. Identification of the S-Endo 1 endothelial-associated antigen. Biochem Biophys Res Commun 1996; 218: 210-216.
17. Bardin N, George F, Mutin M, et al. S-Endo 1, a pan-endothelial monoclonal antibody recognizing a novel human endothelial antigen. Tissue Antigens 1996; 48: 531-539.
18. Anfosso F, Bardin N, Vivier E, Sabatier F, Sampol J, Dignat-George F. Outside-in signaling pathway linked to CD146 engagement in human endothelial cells. J Biol Chem 2001; 276: 1564-1569.
19. Anfosso F, Bardin N, Frances V, et al. Activation of human endothelial cells via S-endo-1 antigen (CD146) stimulates the tyrosine phosphorylation of focal adhesion kinase p125 (FAK). J Biol Chem 1998; 273: 26 852-26 856.
20. Boye E, Yu Y, Paranya G, Mulliken JB, Olsen BR, Bischoff J. Clonality and altered behavior of endothelial cells from hemangiomas. J Clin Invest 2001; 107: 745-752.
21. Kraling BM, Razon MJ, Boon LM, et al. E-selectin is present in proliferating endothelial cells in human hemangiomas. Am J Pathol 1996; 148: 1181-1191.
22. Yu Y, Varughese J, Brown LF, Mulliken JB, Bischoff J. Increased Tie2 expression, enhanced response to angiopoietin-1, and dysregulated angiopoietin-2 expression in hemangioma-derived endothelial cells. Am J Pathol 2001; 159: 2271-2280.
23. Ritter MR, Dorrel MI, Edmonds J, Friedlander SF, Friedlander M. Insulin-like growth factor 2 and potential regulators of hemangioma growth and involution identified by large-scale expression analysis. Proc Natl Acad Sci U S A 2001; 99: 7455-7460.